Dr. Kachlany is an Associate Professor in the Oral Biology Department at Rutgers School of Dental Medicine. Dr. Kachlany obtained his B.S. in microbiology and cellular biology from Cornell University and his Ph.D. from Columbia University College of Physicians and Surgeons. Dr. Kachlany has published more than 40 scientific articles and is recipient of numerous awards and honors; most recently the 2013 Thomas Edison Patent of the Year Award and 2013 New Jersey Inventors Hall of Fame Innovators Award.
Dr. Stuart Cook is Ruth Dunietz Kushner and Michael Jay Serwitz Chair in Multiple Sclerosis and Director of the MS Diagnostic Treatment Center at Rutgers – New Jersey Medical School, Newark, NJ. He received his medical degree from the University of Vermont, trained in neurology at the Albert Einstein College of Medicine, New York, and was a faculty member at that institution, Columbia University and Rutgers Medical School. Dr. Cook was founding Chairman of the Department of Neurosciences at University of Medicine and Dentistry of NJ (prior to merger with Rutgers) for 27 years, as well as Acting Dean, and subsequently President of the University from 1998-2004. His research has been in the area of demyelinating disease, particularly multiple sclerosis (MS) and Guillain-Barré syndrome and his current interests are in the role of infectious agents in triggering MS, the relevance of antiglycolipid antibodies in the disease pathogenesis and therapies of MS.
Dr. Roger Strair is Chief of Hematologic Malignancies and director of the blood and marrow transplant program at Rutgers Cancer Institute of New Jersey and Professor of Medicine at Robert Wood Johnson Medical School in New Brunswick, NJ. Dr. Strair did his medical and graduate training at Albert Einstein College of Medicine and completed a residency in internal medicine and fellowship in hematology/oncology at Harvard Medical School, Brigham & Women’s Hospital. Dr. Strair performs both basic and clinical research and has carried out numerous investigator- and industry-initiated phase I through phase III clinical trials with new, experimental therapies.
Dr. Planet is Assistant Professor of Pediatrics at Columbia University College of Physicians and Surgeons and Morgan Stanley Children’s Hospital. Dr. Planet obtained his medical and graduate degrees from Columbia University College of Physicians and Surgeons and completed residency training in pediatrics and a fellowship in infectious diseases at Morgan Stanley Children’s Hospital. Dr. Planet has authored numerous papers on the etiology and evolution of infectious diseases and treats patients with bacterial, viral (including HIV), and fungal infections.
Hematologic diseases (leukemia, lymphoma, and multiple myeloma) are cancers of white blood cells that are often deadly and difficult to treat. Preclinical efficacy studies have shown that Leukothera™ is highly effective at eliminating malignant white blood cells both under laboratory conditions and in animals.Read More
Autoimmune and inflammatory diseases comprise a range of disorders that are characterized by the abundant presence of chronically activated WBCs. Leukothera® specifically targets these activated WBCs without affecting healthy cells and tissues.Read More
HIV infects white blood cells and can hide from our immune system within them. Current therapies can target replicating virus, but do not eliminate the HIV-infected cells. These infected white blood cells are what prevent any current drugs from curing HIV infection.Read More